Purification of human natural killer cells using a clinical-scale immunomagnetic method

By Iyengar R   Handgretinger R   Babarin-dorner A   Leimig T   Otto M   Geiger Tl   Holladay Ms   Houston J   Leung W  

Cytotherapy, Vol. 5, Iss. 6, 2003-12 ,pp. : 479-484

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Clinical-scale production of granulocyte progenitor and post-progenitor cells using daniplestim, leridistim, Progenipoietin, Promegapoietin and autologous plasma

By Patel S.   Guo R.   Miller W.M.   Papoutsakis E.T.   Minster N.I.   Baum C.M.   Winter J.N.  

Cytotherapy, Vol. 2, Iss. 2, 2000-02 ,pp. : 85-94

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy

By Wong E C C   Maher V E   Hines K   Lee J   Carter C S   Goletz T   Kopp W   Mackall C L   Berzofsky J   Read E J  

Cytotherapy, Vol. 3, Iss. 1, 2001-01 ,pp. : 19-29

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Utilizing regulatory T cells to control alloreactivity

By Hauben E   Bacchetta R   Roncarolo MG  

Cytotherapy, Vol. 7, Iss. 2, 2005-05 ,pp. : 158-165

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Manipulating regulatory T cells

By Barrett Aj  

Cytotherapy, Vol. 9, Iss. 2, 2007-01 ,pp. : 109-110

Ashgate Publishing Ltd

Access to resources Recommend Favorite